{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T05:15:25Z","timestamp":1655270125446},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"unspecified","delay-in-days":2020,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir. j. psychol. med."],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Methadone substitution improves maternal and neonatal outcomes. However methadone induced neonatal abstinence syndrome (NAS) is common. Buprenorphine-exposed neonates may be at a lower risk of NAS. Currently in the Republic of Ireland, buprenorphine does not have a special licence for use in pregnancy. We describe here the history and neonatal outcomes of the first Irish woman maintained on buprenorphine during two pregnancies.<\/jats:p><jats:p>Supervised urinanalysis on this mother between and throughout both pregnancies did not reveal any illicit drug use. She delivered two post-term babies of normal birth weight and length. The second infant required treatment for NAS for 21 days with morphine sulphate. Although the use of buprenorphine in pregnancy does not remove the possibility of NAS, neonatal outcomes of buprenorphine-maintained women compares favourably to methadone. As the use of buprenorphine becomes more established in Ireland, the management of buprenorphine-exposed neonates will become more common.<\/jats:p>","DOI":"10.1017\/s0790966700011265","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T13:12:08Z","timestamp":1458047528000},"page":"141-144","source":"Crossref","is-referenced-by-count":0,"title":["Neonatal outcome following buprenorphine maintenance for opiate dependency"],"prefix":"10.1017","volume":"25","author":[{"given":"John","family":"Fagan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eamon","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"key":"S0790966700011265_ref034","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.03.012"},{"key":"S0790966700011265_ref033","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1542\/peds.101.6.1079","article-title":"Neonatal drug withdrawal","volume":"101","year":"1998","journal-title":"Pediatrics"},{"key":"S0790966700011265_ref032","volume-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs","year":"2005"},{"key":"S0790966700011265_ref031","unstructured":"Summary of Product Characteristics (SPC) from the IPHA Electronic Medicines Compendium, www.medicines.ie"},{"key":"S0790966700011265_ref030","first-page":"39","volume-title":"Pregnancy and drug misuse update 2000","author":"Auriacombe","year":"2000"},{"key":"S0790966700011265_ref027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01321.x"},{"key":"S0790966700011265_ref026","unstructured":"Jones HE , Martin PR , Heil SH et al. Treatment of opioid-dependent Pregnant Women: Clinical and Research Issues. J Subst Abuse Treat in Press (available on-line)."},{"key":"S0790966700011265_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00062-0"},{"key":"S0790966700011265_ref021","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.95223910.x"},{"key":"S0790966700011265_ref017","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00391.x"},{"key":"S0790966700011265_ref016","doi-asserted-by":"publisher","DOI":"10.1007\/BF02002721"},{"key":"S0790966700011265_ref015","doi-asserted-by":"publisher","DOI":"10.3109\/00952998209002641"},{"key":"S0790966700011265_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(03)00154-5"},{"key":"S0790966700011265_ref011","volume-title":"Cochrane Library","author":"Osborn","year":"2004"},{"key":"S0790966700011265_ref010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02877.x"},{"key":"S0790966700011265_ref007","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1991.10472236"},{"key":"S0790966700011265_ref006","unstructured":"Personal correspondence, Drug Liaison Midwives."},{"key":"S0790966700011265_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"S0790966700011265_ref025","first-page":"103","article-title":"The Pharmacology and abuse potential of buprenorphine: a new antagonistic analgesic","volume":"3","author":"Lewis","year":"1983","journal-title":"Adv Subt Abuse"},{"key":"S0790966700011265_ref028","unstructured":"NIDA \u2013 Directors Report \u2013 February 2005. www.nida.nih.gov\/DirReports\/DirRep205\/DirectorsReport13.html"},{"key":"S0790966700011265_ref008","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.95811411.x"},{"key":"S0790966700011265_ref012","first-page":"19","article-title":"Assessment and treatment of abstinence in the infant of the drug dependent mother","volume":"12","author":"Finnegan","year":"1975","journal-title":"Int J Clin Pharmacol"},{"key":"S0790966700011265_ref003","volume-title":"A 3-source Capture Recapture study","author":"Kelly","year":"2003"},{"key":"S0790966700011265_ref014","first-page":"1244","article-title":"Relationship between maternal methadone dosage and neonatal withdrawal","volume":"100","author":"Dashe","year":"2002","journal-title":"Obstet Gynecol"},{"key":"S0790966700011265_ref019","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-34115"},{"key":"S0790966700011265_ref018","first-page":"236","article-title":"Neonatal abstinence syndrome","volume":"92","author":"Coghlan","year":"1999","journal-title":"Ir Med J"},{"key":"S0790966700011265_ref029","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1561"},{"key":"S0790966700011265_ref023","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00245.x"},{"key":"S0790966700011265_ref009","volume-title":"Methadone Maintenance Treatment and Other Opioid Replacement Therapies","author":"Ward","year":"1998"},{"key":"S0790966700011265_ref022","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00600.x"},{"key":"S0790966700011265_ref001","doi-asserted-by":"publisher","DOI":"10.1159\/000076116"},{"key":"S0790966700011265_ref002","volume-title":"Annual report on the state of the drugs problem in the European Union and Norway","year":"2002"},{"key":"S0790966700011265_ref004","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6960.997"},{"key":"S0790966700011265_ref005","first-page":"2","volume-title":"Central Methadone Treatment List, Drug Treatment Central Board, 30-31 Pearse Street"}],"container-title":["Irish Journal of Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0790966700011265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T04:40:04Z","timestamp":1655268004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0790966700011265\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0790966700011265"],"URL":"https:\/\/doi.org\/10.1017\/s0790966700011265","relation":{},"ISSN":["0790-9667","2051-6967"],"issn-type":[{"value":"0790-9667","type":"print"},{"value":"2051-6967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}